Gero
Business Services · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
133 Cecil Street Keck Seng Tower / 14-01...Phone Number
+74952762275Website
www.gero.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Gero
Gero is a physics-first AI drug discovery and development company focused on age-related diseases and the biology of aging. The platform builds AI models of human health from large-scale longitudinal real-world data, combining clinical, molecular, omics, and genetic data with physics-based modeling and AI-enabled target discovery, paired with ProtoBind-Diff, a generative AI model for small-molecule design directly from protein sequence. Gero partners with pharmaceutical companies on age-related disease and advances proprietary programs aimed at intervention in aging itself. Gero's scientific work has been published in Science, Nature Communications, and other leading journals. The company is headquartered in Singapore, with a U.S. subsidiary in San Francisco.Explore more
Gero Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gero your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Gero is spiking on competitors!
Earning: See what the market has to say on Gero recently announced quarterly report
Gero, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Gero has new funding data
Check if Gero has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Gero
Product Launch: Get notified when Gero launches new products
Click to see if Gero had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Gero as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Gero is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Gero is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Gero.
Gero financials insights
Gather financial insights about Gero, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$8.2M
2026
Other Financing Round
$17M
Gero Tech Stack
A closer look at the technologies used by Gero
Most Recent Scoops
Funding
Funding
Executive Move
Executive Moves, Board of Directors
Person-Based
Person-Based
Person-Based
Gero News & Media
Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases
Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related DiseasesGero Launches ProtoBind-Diff, a Structure-Free AI Foundation Model for Targeted Small Molecule Discovery
Gero Launches ProtoBind-Diff, a Structure-Free AI Foundation Model for Targeted Small Molecule DiscoveryHow Will We Defeat Aging? Scientific Debate Ends with $10,000 Cash Prize and Surprising Verdict, Signaling New Investment Opportunities
SAN FRANCISCO--(BUSINESS WIRE)--How Will We Defeat Aging? Scientific Debate Ends with $10K Prize and Surprising Verdict. Halting aging vs rejuvenation New Investment Opportunities?Physics-Powered GenAI Biotech Gero Raises $6M to Find Root Causes of Aging and Age-Related Diseases
PALO ALTO, Calif.--(BUSINESS WIRE)--Gero, a biotechnology company focused on aging and chronic diseases, has closed a $6M Series A extension round.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Gero
Sign Up For FreeTo access detailed company insights
Gero is a physics-first AI drug discovery and development company focused on age-related diseases and the biology of aging. The platform builds AI models of human health from large-scale longitudinal real-world data, combining clinical, molecular, omics, and genetic data with physics-based modeling and AI-enabled target discovery, paired with Proto... Read More
